These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2832096)

  • 1. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK; Ritter AB; Durán WN
    Circ Res; 1988 Apr; 62(4):722-31. PubMed ID: 2832096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
    Dillon PK; Durán WN
    Circ Res; 1988 Apr; 62(4):732-40. PubMed ID: 2450695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch.
    Kim DD; Ramírez MM; Durán WN
    Microvasc Res; 2000 Jan; 59(1):7-13. PubMed ID: 10625566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance and exchange microvessels are modulated by different PAF receptors.
    Tomeo AC; Durán WN
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1648-52. PubMed ID: 1659229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute microcirculatory effects of platelet-activating factor.
    Durán WN; Dillon PK
    J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
    Verbeuren TJ; Vallez MO; Lavielle G; Bouskela E
    Br J Pharmacol; 1997 Nov; 122(5):859-66. PubMed ID: 9384501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation.
    Kim D; Durán WN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H399-403. PubMed ID: 7530921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
    Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
    Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcirculatory dynamics of neuropeptide Y.
    Kim D; Durán WR; Kobayashi I; Daniels AJ; Durán WN
    Microvasc Res; 1994 Jul; 48(1):124-34. PubMed ID: 7990718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute microvascular effects of PAF-acether, as studied by intravital microscopy.
    Björk J; Smedegård G
    Eur J Pharmacol; 1983 Dec; 96(1-2):87-94. PubMed ID: 6662199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel neuropeptide Y receptor antagonists block vasoconstriction in the hamster cheek pouch microcirculation.
    Kim D; Durán WT; Daniels AJ; Durán WN
    Microvasc Res; 1997 Mar; 53(2):167-72. PubMed ID: 9143549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longchain n-3 polyunsaturated fatty acids and microvascular reactivity: observation in the hamster cheek pouch.
    Conde CM; Cyrino FZ; Bottino DA; Gardette J; Bouskela E
    Microvasc Res; 2007 May; 73(3):237-47. PubMed ID: 17196224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C.
    Kobayashi I; Kim D; Hobson RW; Durán WN
    Am J Physiol; 1994 Mar; 266(3 Pt 2):H1214-20. PubMed ID: 8160825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming interactions between platelet activating factor and histamine in the in vivo microcirculation.
    Tomeo AC; Egan RW; Durán WN
    FASEB J; 1991 Oct; 5(13):2850-5. PubMed ID: 1655549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X; Han GQ; Li RZ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):672-6. PubMed ID: 2983307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
    Klabunde RE; Anderson DE
    Eur J Pharmacol; 2000 Sep; 404(3):387-94. PubMed ID: 10996604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of platelet-activating factor on arteriolar and venular tone in rat trachea.
    Collins LC; Roberts AM
    Microvasc Res; 1997 Jan; 53(1):63-72. PubMed ID: 9056476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature.
    Kim DD; Kanetaka T; Durán RG; Sánhez FA; Bohlen HG; Durá WN
    Microcirculation; 2009 May; 16(4):323-30. PubMed ID: 19235626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist.
    Montrucchio G; Alloatti G; Mariano F; Tetta C; Emanuelli G; Camussi G
    Int J Tissue React; 1986; 8(6):497-504. PubMed ID: 3025124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.